Clearside Biomedical Performance
| CLSDDelisted Stock | USD 0.41 0.16 28.07% |
The firm shows a Beta (market volatility) of 1.09, which signifies a somewhat significant risk relative to the market. Clearside Biomedical returns are very sensitive to returns on the market. As the market goes up or down, Clearside Biomedical is expected to follow. At this point, Clearside Biomedical has a negative expected return of -10.79%. Please make sure to confirm Clearside Biomedical's jensen alpha and the relationship between the value at risk and day typical price , to decide if Clearside Biomedical performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days Clearside Biomedical has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of inconsistent performance in the last few months, the Stock's basic indicators remain rather sound which may send shares a bit higher in March 2026. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders. ...more
| Begin Period Cash Flow | 28.9 M | |
| Total Cashflows From Investing Activities | -638 K |
Clearside |
Clearside Biomedical Relative Risk vs. Return Landscape
If you would invest 368.00 in Clearside Biomedical on November 9, 2025 and sell it today you would lose (327.00) from holding Clearside Biomedical or give up 88.86% of portfolio value over 90 days. Clearside Biomedical is currently does not generate positive expected returns and assumes 18.91% risk (volatility on return distribution) over the 90 days horizon. In different words, most equities are less risky than Clearside, and most traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Clearside Biomedical Target Price Odds to finish over Current Price
The tendency of Clearside Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 0.41 | 90 days | 0.41 | close to 99 |
Based on a normal probability distribution, the odds of Clearside Biomedical to move above the current price in 90 days from now is close to 99 (This Clearside Biomedical probability density function shows the probability of Clearside Stock to fall within a particular range of prices over 90 days) .
Clearside Biomedical Price Density |
| Price |
Predictive Modules for Clearside Biomedical
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Clearside Biomedical. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Clearside Biomedical's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Clearside Biomedical Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Clearside Biomedical is not an exception. The market had few large corrections towards the Clearside Biomedical's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Clearside Biomedical, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Clearside Biomedical within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -3.08 | |
β | Beta against Dow Jones | 1.09 | |
σ | Overall volatility | 1.06 | |
Ir | Information ratio | -0.27 |
Clearside Biomedical Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Clearside Biomedical for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Clearside Biomedical can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Clearside Biomedical is not yet fully synchronised with the market data | |
| Clearside Biomedical generated a negative expected return over the last 90 days | |
| Clearside Biomedical has high historical volatility and very poor performance | |
| Clearside Biomedical has some characteristics of a very speculative penny stock | |
| Clearside Biomedical has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 1.66 M. Net Loss for the year was (34.35 M) with profit before overhead, payroll, taxes, and interest of 2.93 M. | |
| Clearside Biomedical currently holds about 29.03 M in cash with (24.7 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.48, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Roughly 13.0% of the company shares are held by company insiders |
Clearside Biomedical Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Clearside Stock often depends not only on the future outlook of the current and potential Clearside Biomedical's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Clearside Biomedical's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 4.9 M | |
| Cash And Short Term Investments | 20 M |
Clearside Biomedical Fundamentals Growth
Clearside Stock prices reflect investors' perceptions of the future prospects and financial health of Clearside Biomedical, and Clearside Biomedical fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Clearside Stock performance.
| Return On Equity | -13.1 | |||
| Return On Asset | -0.7 | |||
| Operating Margin | (35.02) % | |||
| Current Valuation | (2.33 M) | |||
| Shares Outstanding | 5.23 M | |||
| Price To Earning | 130.00 X | |||
| Price To Book | 3.93 X | |||
| Price To Sales | 0.64 X | |||
| Revenue | 1.66 M | |||
| EBITDA | (24.35 M) | |||
| Cash And Equivalents | 29.03 M | |||
| Cash Per Share | 0.48 X | |||
| Total Debt | 52.47 M | |||
| Debt To Equity | 0.02 % | |||
| Book Value Per Share | (10.31) X | |||
| Cash Flow From Operations | (24.7 M) | |||
| Earnings Per Share | (5.11) X | |||
| Total Asset | 25.13 M | |||
| Retained Earnings | (355.27 M) | |||
| Current Asset | 20.48 M | |||
| Current Liabilities | 5.2 M | |||
About Clearside Biomedical Performance
By analyzing Clearside Biomedical's fundamental ratios, stakeholders can gain valuable insights into Clearside Biomedical's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Clearside Biomedical has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Clearside Biomedical has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Clearside Biomedical, Inc., a biopharmaceutical company, focuses on the revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space. Clearside Biomedical, Inc. was incorporated in 2011 and is headquartered in Alpharetta, Georgia. Clearside Biomedi operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 34 people.Things to note about Clearside Biomedical performance evaluation
Checking the ongoing alerts about Clearside Biomedical for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Clearside Biomedical help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Clearside Biomedical is not yet fully synchronised with the market data | |
| Clearside Biomedical generated a negative expected return over the last 90 days | |
| Clearside Biomedical has high historical volatility and very poor performance | |
| Clearside Biomedical has some characteristics of a very speculative penny stock | |
| Clearside Biomedical has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 1.66 M. Net Loss for the year was (34.35 M) with profit before overhead, payroll, taxes, and interest of 2.93 M. | |
| Clearside Biomedical currently holds about 29.03 M in cash with (24.7 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.48, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Roughly 13.0% of the company shares are held by company insiders |
- Analyzing Clearside Biomedical's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Clearside Biomedical's stock is overvalued or undervalued compared to its peers.
- Examining Clearside Biomedical's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Clearside Biomedical's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Clearside Biomedical's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Clearside Biomedical's stock. These opinions can provide insight into Clearside Biomedical's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.
Other Consideration for investing in Clearside Stock
If you are still planning to invest in Clearside Biomedical check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Clearside Biomedical's history and understand the potential risks before investing.
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated |